Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Harvard Business School
Moodys
Dow
Merck
Express Scripts
Chinese Patent Office
McKinsey

Generated: February 17, 2019

DrugPatentWatch Database Preview

Details for Biologics License Application: 125427

« Back to Dashboard

Summary for BLA: 125427
Tradename:KADCYLA
Applicant:Genentech
Ingredient:ado-trastuzumab emtansine
Patents:9
Approval Date:Feb 22, 2013
Suppliers: see list1

US Patents for BLA: 125427

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech KADCYLA ado-trastuzumab emtansine VIAL; SINGLE-USE 125427 001 2013-02-22 ➤ Sign Up Array BioPharma Inc. (Boulder, CO) ➤ Sign Up RX search
Genentech KADCYLA ado-trastuzumab emtansine VIAL; SINGLE-USE 125427 001 2013-02-22 ➤ Sign Up University of Georgia Research Foundation, Inc. (Athens, GA) ➤ Sign Up RX search
Genentech KADCYLA ado-trastuzumab emtansine VIAL; SINGLE-USE 125427 001 2013-02-22 ➤ Sign Up Merrimack Pharmaceuticals, Inc. (Cambridge, MA) ➤ Sign Up RX search
Genentech KADCYLA ado-trastuzumab emtansine VIAL; SINGLE-USE 125427 001 2013-02-22 ➤ Sign Up Deciphera Pharmaceuticals, LLC (Lawrence, KS) ➤ Sign Up RX search
Genentech KADCYLA ado-trastuzumab emtansine VIAL; SINGLE-USE 125427 001 2013-02-22 ➤ Sign Up Riptide Bioscience, Inc. (Vallejo, CA) ➤ Sign Up RX search
Genentech KADCYLA ado-trastuzumab emtansine VIAL; SINGLE-USE 125427 001 2013-02-22 ➤ Sign Up GI Therapeutics, Inc. (Research Triangle Park, NC) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Dow
QuintilesIMS
Teva
Medtronic
Julphar
Express Scripts
Cantor Fitzgerald
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.